OBJECTIVES: 'The David technique' may provide an alternative to conduit implantation in patients with an aneurysm of the ascending aorta and aortic valve insufficiency.
INTRODUCTION
Aortic valve-sparing operations for the treatment of aortic insufficiency (AI) or aortic root dilatation with aneurysm of the aorta have been performed by many institutions, with outstanding longterm results [1] [2] [3] .
Several modifications have been presented over the years [4, 5] . The advantages of aortic valve-preserving procedures seem obvious, because no anticoagulation is necessary, in contrast to the use of mechanical valves, and there is no limit to durability as is the case for bioprosthetic valves. Over the past 22 years, we have performed 249 David procedures and developed modifications, such as a technique for creation of sinuses. In the present study, we focused on the postoperative and follow-up results and compared patients without (group 1) and those with deterioration of valve function defined as reoperation or AI ≥ 2°(group 2). We tried to identify risk factors and their impact on late outcome.
PATIENTS AND METHODS
From 1991 to 2013, 249 consecutive patients with an ascending aortic aneurysm and aortic valve insufficiency underwent replacement of the ascending aorta and resuspension of the aortic valve in our department. Their mean age was 58 ± 14 years (range 18-87 years). Table 1 summarizes the characteristics of the patients. The operative technique has been described in former publications [6] . Until 2004, we performed the standard David technique [7] . Later, we modified the procedure, initially by creating a pseudosinus to reduce leaflet stress [6] . For this, we took a graft size with a diameter twice the leaflet height. In patients with a normal, non-dilated annulus, the size of graft was caculated by the annular diameter, adding about 2 mm for aortic wall thickness and an additional 5 mm in order to create the pseudosinus. At the base of each commissure, 5 mm triangular bites were passed parallel and perpendicular to the lower edge of the prosthesis. In a previous publication, we showed that the valve opening velocity could be reduced in patients who received the pseudosinus procedure in comparison to the standard David technique in our institution.
As a next step, we created a neosinus [4] to optimize the aortic cusp dynamics by lowering the valve opening velocity compared with the pseudosinus technique and reducing leaflet stress [8] . We plicated the base and the sinotubular junction of the graft with three 4-0 braided polyester sutures. At the base of each commissure, 5-7 mm bites were passed parallel to the lower edge of the prosthesis. The second bite of the same suture was passed perpendicularly to the first, in order to catch 5 mm of prosthesis height. Placing three stitches at the base in this fashion reduces the diameter and local height of the base and creates a more physiological protrusion of the graft. Bites for resuspension of the commissures were taken 5-7 mm wider at the prostheses. This created the anatomical diameter reduction of the sinotubular junction. Again, three 4-0 stitches were placed at the outside to reinforce the diameter reduction, and the perpendicular bites again reduced the height at the commissures to increase the bulge of the sinuses.
In cases of bicuspid aortic valves, we modified the David procedure, mainly by augmenting the fused leaflet with a patch [9] . To avoid distortion of the right coronary cusp, the deepest or 'central' stitch at the right sinus was placed in a supra-annular position, because the prostheses cannot be brought down below the annulus owing to the septal muscle shelf [10] . We performed this step in 48 patients (all in group 1).
The function of the aortic valve was determined intraoperatively with transoesophageal echocardiography. Transthoracic echocardiograms were performed before discharge from the hospital and at follow-up.
Patients did not receive oral anticoagulants except when indicated by additional disease.
Ten patients were lost to follow-up (95% complete). The mean follow-up was 5.7 ± 4.5 years, with 1239 cumulative patient-years.
We compared patients without (group 1, n = 227) and those with deterioration of valve function defined as reoperation or AI ≥ 2°(group 2, n = 22). We tried to identify risk factors and their impact on late outcome using univariate analysis between the two groups.
The study was approved by our institutional ethics committee.
Statistical analysis
All statistical analyses were performed with BIAS 9.05 software (Epsilon Publishing, Darmstadt, Germany). Categorical variables are expressed as frequencies. Continuous variables are expressed as means ± SD. Long-term survival, freedom from reoperation and freedom from moderate or severe AI were calculated according to the Kaplan-Meier method and compared by log-rank test between patient groups. Logistic regression models were used to analyse independent associations with postoperative AI ≥ 2°or reoperation; univariate analysis was performed with the log-rank test (Peto-Pike/Cox-Mantel) between the patient groups (Tables 1-4 ). There were few adverse events in our series, and the number of patients in some subgroups was also too small for generating significant multivariate analysis.
RESULTS

Perioperative outcome
The in-hospital mortality was 2.4% (n = 6) in total. Three patients died of multiorgan failure, two of low-output syndrome (one of them belonged to group 2) and one of rupture of an abdominal aneurysm. We noticed four neurological events perioperatively; all of these patients belonged to group 1. One patient had temporary and three permanent neurological deficits (two with critical illness polyneuropathy and one focal event). Table 2 illustrates the perioperative results and surgical procedures. There were no relevant differences in cardiopulmonary bypass time, myocardial ischaemic time, intensive care unit stay or ventilation time between the two groups; however, there were significant differences in operative techniques. In group 1, more operations made use of the neosinus technique (118 vs 5, P = 0.03) and more supra-annular stitches (48 vs 0, P = 0.02) were performed. Performance of the neosinus technique or of the supra-annular stitch emerged as protective against the development of postoperative AI ≥ 2°or reoperation by univariate analysis.
Follow-up
We registered 29 late deaths in group 1 and one in group 2. One patient died of rupture of the descending aorta and three had rupture of the abdominal aorta. One patient suffered from respiratory failure, two from gastrointestinal bleeding and another one from lung cancer. Two patients died of sepsis and one of acute The linearized late mortality event rate for group 1 patients was 2.6%/patient-year and for group 2 patients 0.75%/patient-year (P = 0.2). Figure 1 shows the Kaplan-Meier survival curve for the whole series.
Six patients of group 1 had late neurological events (0.5%/ patient-year); five with focal transitory neurological events and one fatal cerebral bleed, as mentioned above. We observed two late focal neurological deficits in group 2 (1.5%/patient-year); this difference was not significant (P = 0.2).
We observed three bleeding events in group 1 patients at follow-up (0.27%/patient-year); two patients suffered from gastrointestinal and one from cerebral bleeding, as mentioned above.
The linearized reoperation rate in total was 0.8%/patient-year (10 in 1239 patient-years). We observed four cases of endocarditis with severe AI; two of them had bicuspid aortic valves. All four patients underwent reoperation. Structural valve failure with severe AI was the cause of reoperation in five patients (three with leaflet prolapse, one with leaflet perforation and one with torsion of the right coronary leaflet). One other patient had to be reoperated for combined aortic valve disease. In patients who later underwent reoperation, echocardiography showed no significant AI (eight with AI grade 0; two with AI grade 1) early after surgery. Six of the 10 reoperated patients had no leaflet plication at repair, and the supra-annular stitch was not performed at repair in all 10 patients. Only two of the 10 reoperated patients had the neosinus modification at the time of repair. In all 10 reoperated patients, the aortic valve had to be replaced with a biological (n = 1) or mechanical prosthesis (n = 9). The 10-year freedom from reoperation was 88% in our series (Fig. 2) .
The echocardiographic data are listed in Table 4 . At latest follow-up, only 10 patients had AI = 2°. The freedom from AI ≥ 2°o r reoperation at 10 years was 80% (Fig. 3) . At the time of last follow-up, 173 patients (85%) were in New York Heart Association functional class I, 22 patients (11%) were in class II and eight patients (4%) in class III.
DISCUSSION
The aortic valve-sparing operation is a complex procedure because the aortic valve and the aortic root have to be considered as a geometric and functional unit when using the reimplantation technique. Any change in part of that functional unit has consequences for the overall result, e.g. the development of AI. Reimplantation is a reliable technique, as data provided by many investigators prove [11] [12] [13] . In our study, we aimed to find out if there are any protective parameters against the development of AI ≥ 2°or reoperation; therefore, we examined the data from 249 patients operated with the reimplantation technique and modifications in our institution by using univariate analysis. We could not find preoperative parameters that had a significant influence on the development of AI ≥ 2°or reoperation, as Table 1 shows. However, there were operative modifications with significant effects in univariate analysis. Performance of the neosinus technique (P = 0.03) or of the supra-annular stitch (P = 0.02) emerged as protective against the development of postoperative AI ≥ 2°or reoperation. The in-hospital mortality of our series is 2.4%, which is comparable to other reports [11] . The 9-year survival was 80% in our series, which is also comparable to that described in other reports, ranging between 83 and 92% [11, 12] . Valve-related complications after reimplantation are fewer compared with conduit root replacement [14] . The linearized rate of stroke and death for both groups (3.1%/patient-year; 38 in 1239 patient-years) was lower than that reported by Etz et al. after the Bentall procedure (5.6%/patient-year; 33 in 585 patient-years) [15] . Bleeding complications in patients receiving mechanical conduits were reported at 1.8%/patient-year (10 in 571 patient-years) by Hagl et al. [14] , which is a higher rate than in our reimplantation series (0.24%/patient-year; three in 1239 patient-years). The endocarditis rate of our series was 0.32%/patient-year in total, which is similar to the rate of 0.35%/patient-year reported for the Bentall procedure [14] . Also similar is our linearized reoperation rate of 0.8%/ patient-year in total compared with the rate for the Bentall procedure, which is described as 0.7%/patient-year [14] . The 9-year freedom from reoperation ranges between 81 and 98% [11] in the literature and compares well to our series (90% at 9 years; Fig. 2 ). Kallenbach and colleagues described an 80% 9-year freedom from reoperation after the David operation [12] . A 5-year freedom from reoperation rate of 95.9% is described by the Leipzig group [16] , which again compares to the 5-year freedom rate of 98% for our series (Fig. 2) .
Six of the 10 reoperated patients had no leaflet plication at repair. Cusp plication had no significant influence on the development of postoperative AI ≥ 2°or reoperation (P = 0.3) in univariate analysis. However, leaflet plication has also been reported by Kunihara et al. to have a positive influence on freedom from AI [11] . We found out that the performance of a supra-annular stitch at the right coronary base was significantly protective against the development of postoperative AI ≥ 2°or reoperation (P = 0.02) in univariate analysis, because none of the 10 reoperated patients had a supra-annular stitch used at the time of repair. In 20% of the reoperated patients, the AI grade at the time of repair was 1, which is also an important fact. Maybe we should also think about revision of the operative result at the time of repair in cases of AI grade 1 in order to achieve AI grade 0. However, 80% of the reoperated patients had AI grade 0 at the time of repair. Another factor for reoperation could be the experience of the performing surgeon at the time of repair. Here more studies are necessary to show whether there is a difference in the operative results depending on the experience of the surgeons in the same institution. We also observed a positive effect of the neosinus technique on the development of postoperative AI ≥ 2°or reoperation in univariate analysis (P = 0.03), because only two of the 10 reoperated patients had the neosinus modification at the time of repair. In our series, freedom from AI ≥ 2°or reoperation at 10 years was 80% and at 14 years 73% (Fig. 3) .
Our data show a low valve-related complication rate after aortic valve reimplantation. Late valve deterioration is rare and does not necessitate more reoperations, which have been reported for conduit root replacement. Given that the repair does not provide an indication for oral anticoagulation, in fact no valve-related bleeding occurred. Focal neurological events and the rate of endocarditis were rare, and lower than in most reports after conduit replacement. Technical modifications (such as the neosinus technique or performance of the supra-annular stitch) to optimize the geometry of the resuspended aortic valve can virtually eliminate late valve failure. Further studies with a larger number of patients are necessary to strengthen our findings.
Study limitations
There are few adverse events in our series, and the number of patients in some subgroups is also too small for generating significant multivariate analysis.
Dr Monsefi: Over 70% of the follow-up echos were performed in our unit. The patients were contacted by phone or by letter by our study analyst, and some of the patients had their own cardiologists. So we went on and asked them to send us, for example, the data or the CDs, and we evaluated them also.
Dr Guo: The second question is regarding your modifications. So you did pseudo-sinuses, neo-sinuses, and you also used supra-annular sutures. Actually so far there is no literature to support that all those modifications have improved long-term outcomes, although some in vitro studies proved that those sinus modifications improved mobility of the leaflet. What is your comment about that?
Dr Monsefi: That is a very interesting question. Yes, I was wondering myself, because in the last publication of David himself, the neo-sinus technique had no significant influence on postoperative AI. Maybe these observations would be strengthened by larger patient numbers or a randomized study. That could be one answer. Another point could be if the results are surgeon-dependent. If an institution has many surgeons who perform the David procedure with less or more experience, maybe the results are different.
Dr Guo: The next question is that papers published by Dr. Schäfers and by Dr. David have demonstrated that coaptation height, leaflet prolapse and residual regurgitation at the end of the procedure are significant predictors for long-term outcome. Have you been able to tease out those subgroups?
Dr Monsefi: Well, we did not measure the coaptation height. But, for example, residual AI at the time of repair could have a significant influence. Fifty percent of the patients who had residual AI in the follow-up had AI grade 1 at the time of repair and the other 50% had 0. But I think further studies are necessary to prove this.
Dr Guo: My final question is that I just noticed that you operated on a patient who was 87 years old. Do you put any age limitation on this procedure? Dr Monsefi: In our institution the youngest one was 18 and the oldest 87, and we did not impose an age limitation. But it also depends on the condition of the patient. For example, if the David procedure is a little bit complex, then only valve replacement, and if the condition of the patient is not good enough, we would not proceed.
